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Abstract
MRI has recently been presented as a nondestructive in vivo readout to report perfusion
capacity in biomaterials planted on the CAM in the living chick embryo in ovo. Per-
fusion capacity was assessed through changes in T1 relaxation pre- and post-injection
of a paramagnetic contrast agent, Gd-DOTA (Dotarem®). Hence local contrast agent
concentration was dependent on perfusion, vascular permeability, and extravascular
compartment size. In the present study we, therefore, explore intravascular SPIO par-
ticles of the FeraSpin® series to deliver a more direct measure of vascularization in a
3D polymer DegraPol® scaﬀold. Furthermore, we present contrast enhancement upon
SPIOs of diﬀerent particle size, namely FeraSpin® series XS, M, XXL and Endorem® for
comparison, and hence diﬀerent eﬃciency on T1 and T2, and study respective dose-
eﬀects. No signal change was observed within the egg yolk, consistent with the SPIO
remaining in the vasculature. Consequently, T1 positive signal enhancement (reduction
in T1) and T2 negative contrast (reduction in T2) were observed only in the vasculature
and hence were restricted mainly to the surface of the CAM at the interface to the bio-
material. Furthermore, the eﬀect upon T2 appears stronger than in T1 with all SPIOs
investigated and at blood concentrations between 0.46 mM to 4.65 mM. Comparison of
diﬀerent concentrations shows larger T1 enhancement at the highest dose, as expected.
Vessel structures in and around the scaﬀold as seen in MRI were corroborated by histol-
ogy. Diﬀerent particle sizes show reduced T1 eﬀect with larger particles, yet the eﬀect
on T2 was less apparent. In sum, SPIO-enhanced MRI provides measures for vascular-
ization nondestructively in biomaterials connected to the CAM, based on intravascular
contrast enhancement in T1 and T2, in ovo in the living chick embryo. Small SPIOs pro-
vide the best eﬃciency for that purpose, and contrast enhancement is most prominent
in T2.
Introduction
Tissue-engineered biomaterials in regenerative medicine provide a matrix for cells to
attach and proliferate, stimulate angiogenesis and sustain long-term function and sur-
vival of the implant. The chorioallantoic membrane (CAM) of the chick embryo is a
model for studying vascularization in vivo [1]. As a consequence, eﬀects of the bioma-
terial’s volume, pore size and pore interconnectivity on the vascularization capacity can
be studied [2].
Recently, anMRI method was presented as a nondestructive in vivo readout of perfusion
capacity in biomaterials planted on the CAM in the living chick embryo in ovo [3]. Per-
fusion capacity was assessed in various scaﬀold materials through changes in T1 relax-
ation pre- and post-injection of a paramagnetic contrast agent, Gd-DOTA (Dotarem®,
Guerbet S.A.). Hence, local contrast agent concentration was dependent not only on
perfusion but also on vascular permeability and extravascular compartment size, as Gd-
DOTA diﬀuses into the interstitial space, particularly in “leaky” vessels. This is a diﬀer-
ent contrast compared to what is seen with blood pool agents staying in the vasculature.
In the present study, intravascular SPIO particles of the FeraSpin® series (Viscover, Mil-
tenyi Biotec, Germany) are therefore explored to deliver a more direct measure of vascu-
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larization/ vessel architecture in 3D DegraPol® scaﬀolds (ab medica, Italy). We present
contrast enhancement upon SPIOs of diﬀerent size, namely FeraSpin® series XS, M, XXL
and Endorem® (Guerbet S.A.) for comparison, and hence diﬀerent eﬃciency on T1 and
T2 and investigate respective dose eﬀects.
Objective
To assess contrast enhancement in a 3D polymer (DegraPol®) scaﬀold upon injection
of SPIOs as intravascular contrast agents in the CAM assay. SPIO particles of diﬀerent
size were used and dosages varied.
a
Figure Legend
Figure 1. SPIO-enhancedMRI to assess vascularization of 3DDegrapol scaﬀolds
planted on the chorioallantoic membrance of the chick embryo in ovo.
A MRI anatomy of the CAM/scaﬀold construct planted on the chicken embryo in ovo.
Left: Picture was taken from the opened egg showing the plastic rings with the scaﬀolds
inside as they were planted on the CAM surface. Red line denotes the sagittal slice
imaged with MRI covering the two scaﬀolds. Right: T1w and T2w MR images taken
from the sagittal slice. Denoted are the structures as visible with the MRI such as parts
of the chicken embryo, egg yolk, plastic rings, scaﬀold.
B SPIO contrast enhancement. In ovo T1w (TR 800 ms, TE 9.3 ms) and T2w (TR 4.5 s,
TE 83.7 ms) MRI images and corresponding color-coded quantitative T1 and T2 maps
acquired in a sagittal slice through an Optimaix-3D™ scaﬀold. Images shown zoomed
into the plastic ring containing the scaﬀold. Vessel structures on the CAM are indicated
by arrowheads and show contrast enhancement in T1 (positive, signal increase) and T2
(negative, signal reduction) upon FeraSpin® M administration at a dose corresponding
to 0.46 mM concentration in blood upon injection. Left to right: pre-, 8 and 140 min
post-injection and after a second dose.
C Dose-dependent SPIO contrast enhancement and comparative histology. In ovo T1w-
and T2w MR images of a DegraPol® scaﬀold and surrounding vessels at diﬀerent SPIO
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concentrations (FeraSpin® XS). Vessel structures are indicated by arrowheads and cor-
roborated by H & E histology. Enhancement in T1 and T2 is highest at the highest dose.
D T1 and T2 eﬃciency for contrast enhancement. T1w and T2w MR images of
two Degrapol® scaﬀolds, planted on the CAMs of two eggs, pre- and post-injection of
Feraspin® XS (left) and Endorem (right) SPIO particles, respectively, showing qualitative
T1 and T2 contrast enhancement upon the two diﬀerent contrast agents. Contrast en-
hancement is more prominent in T2 than T1 with both SPIOs at 4.65 mM concentration.
Larger vessels display largest T2 eﬀect (signal reduction), outweighing T1 enhancement
and hence appear dark in T1w images (“T2-shine-through”).
E T1 and T2 eﬃciency with particle size. Contrast enhancement in T1w and T2w MR
images of twoDegrapol® scaﬀolds, planted on the CAMs of three eggs, upon injection of
diﬀerent sizes of particles from the same Feraspin® SPIO particle family. Feraspin® XS
10-20 nm, M 30-40 nm, and XXL 60-70 nm hydrodynamic diameter, respectively, show
reduced T1 eﬀect with larger particle size, as expected; the eﬀect on T2 is not apparent
at 0.46 mM concentration.
F Analysis of contrast enhancement within the scaﬀold. Histograms of color-coded
quantitative T1 and T2 maps obtained pre- and post-injection were analyzed within the
scaﬀold. Increase in the blue channel– corresponding to decrease in T1 and T2 values– is
shown as a measure of contrast enhancement and depicted with respect to SPIO particle
size and SPIO concentration of the contrast agent. Only data for T2 are shown which
revealed an appreciable trend.
Results & Discussion
MR images were obtained from one sagittal slice positioned through the scaﬀold(s)
planted on the CAM of the chicken embryos (Figure 1A). A medetomidine anesthesia
protocol oﬀered proper sedation of the chick embryo throughout the MRI acquisition
and the scaﬀold was clearly and reproducibly depicted.
No signal change was observed within the egg yolk, consistent with the SPIO remaining
in the vasculature. Consequently, T1 positive signal enhancement (reduction in T1) and
T2 negative contrast (reduction in T2) were observed, consistently in all samples, in the
vasculature and hence were restricted mainly to the surface of the CAM at the interface
to the scaﬀold material where vessel density is highest (Figure 1B). The eﬀect upon T2
appears stronger than in T1 with FeraSpin® M particles at 0.46 mM concentration in the
Optimaix-3D™ scaﬀold.
Remarkably, no change in contrast was observed inside the scaﬀold, which might relate
to partial volume eﬀects between the small vascular compartment as compared to the
scaﬀold structure, but also to our observation that the slightly viscous contrast agent
did not distribute easily but rather slowly within the ﬁner segments of the vasculature,
like the vessels penetrating the scaﬀold. Consistent with this notion are the viscous
quality of the FeraSpin® SPIO preparation and the observation that T1 and T2 contrast
enhancement was more prominently seen at 140 min than 8 min after injection of the
SPIO. Dose escalation from a second SPIO injection did not result in notable further
contrast enhancement, possibly for the same reason.
Qualitative comparison of diﬀerent FeraSpin® XS concentrations shows larger T1 en-
hancement at the highest dose, as expected (Figure 1C). For comparison, doses typically
suggested for use in mice are in a similar range, such as 0.66 mM (mouse example from
manufacturer administering 0.1 mL of 10 mM FeraSpin®) and about 9 mM used for q-
mapping [4], administeringmonocrystalline iron oxide nanoparticlesMION at 30mg/kg
body weight. Vessel structures as seen in MRI are corroborated by histology.
T1 and T2 eﬃciency for contrast enhancement is dependent on relaxivity of the SPIO
particles and hence on particle size, as well as on clearance of the contrast agent from
the blood compartment (blood circulation time itself dependent on particle size). T1
and T2 contrast enhancement with FeraSpin XS® and Endorem® in Degrapol® scaﬀolds
is depicted in ﬁgure 1D for comparison. At the same contrast SPIO concentration
(4.65 mM) contrast enhancement appears more prominent in T2 than in T1. Moreover,
larger vessels present strong T2 eﬀect (signal reduction) outweighing T1 enhancement
(signal increase) and hence appear dark in T1w images due to these competing eﬀects
(“T2-shine-through”).
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T1 and T2 eﬃciency of diﬀerent particle sizes of the FeraSpin® SPIO particle family are
shown in ﬁgure 1E. Feraspin® particles with XS 10–20 nm, M 30–40 nm, and XXL 60–70
nm hydrodynamic diameter, respectively, show reduced T1 eﬀect with larger particle
size, as expected; eﬀect on T2 (larger eﬀect/signal reduction with increasing particle
size) is not apparent at 0.46 mM concentration.
Quantitative analysis of contrast enhancement within the whole scaﬀold revealed the
same trends as observed qualitatively in the MR images (Fig. 1F).
Conclusions
Our data demonstrate that SPIO-enhanced MRI is feasible in the chick embryo in the
CAM assay. SPIO-enhanced MRI provides measures for vascularization nondestruc-
tively in biomaterials connected to the CAM, based on intravascular contrast enhance-
ment in T1 and T2, in ovo in the living chick embryo. Small SPIOs provide the best
eﬃciency for that purpose, and contrast enhancement is most prominent in T2.
Limitations
We comparedMR images qualitatively for contrast enhancement and to the correspond-
ing histological sections. In our MR assessments, the intravascular contrast was most
apparent in large vessels directly at the interface between the CAM and the biomate-
rial planted on it. We are now working on a quantitative assessment of this region in
order to quantify the eﬀect of diﬀerent SPIO particle sizes and concentrations of SPIOs
applied. A thorough detailed quantitative analysis, however, requires:
-more samples per condition (SPIO particle type, concentration) and,
-to tackle dependence on ROI selection, as it varies greatly with positioning within the
scaﬀold (especially when touching the more vascularized region towards the interface
to the CAM), the size of the selected ROI (due to partial voluming between vessels and
scaﬀold material), and the eﬀect of single big vessels. Alternatively, a well-deﬁned con-
trol region within the yolk may be impeded by the motion of the chick embryo between
pre/post-injection MRI sessions.
Yet, a quantitative assessment of the scaﬀold region with the purpose to quantify the
eﬀect of diﬀerent SPIO particle sizes and concentrations of SPIOs was conducted using
a histogram analysis of color-coded T1 and T2 maps, which allowed to assess the more
subtle signal changes within the scaﬀold region. This analysis conﬁrmed contrast en-
hancement (reﬂected in the increase in the blue distribution, which in turn corresponds
to decrease in T1 and T2 relaxation times within the scaﬀold, upon contrast agent ad-
ministration) and reproduced the trends observed qualitatively, as described above, for
the interface region between CAM and scaﬀold (Figure 1F): Larger eﬀects were observed
at higher contrast agent concentrations, and contrast enhancementwasmore prominent
in T2 than T1. Furthermore, increased eﬀect on T2 was expected, and observed, with
increased particle size (in the FeraSpin® series, not Endorem, however) in the scaﬀold
region, while eﬀect on T1was expected to be reduced but was not obvious in the scaﬀold
region, arguably due to underlying T2-eﬀects (T2 shine-through).
Full thorough quantitative analysis of contrast enhancement, in particular within the
scaﬀold, requires more samples per condition and was replaced by a semi-quantitative
histogram-based analysis on our preliminary data, which is supposedly more sensitive
towards smaller signal changes within the scaﬀold. Results from this analysis repro-
duced the qualitative observations/trends seen in the (more obvious) interface region
between the CAM and scaﬀold.
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